National glycopeptide-resistant enterococcal bacteraemia surveillance Working Group report to the Department of Health - August 2004

J Hosp Infect. 2006 Mar:62 Suppl 1:S1-27. doi: 10.1016/j.jhin.2005.04.011. Epub 2005 Dec 9.

Authors

D F J Brown¹, N M Brown, B D Cookson, G Duckworth, M Farrington, G L French, L King, D Lewis, D M Livermore, B Macrae, G M Scott, D Williams, N Woodford

Affiliation

¹ Clinical Microbiology and Public Health Laboratory, Health Protection Agency, Addenbrooke's Hospital, Cambridge CB2 2QW, UK. dfjb2@cam.ac.uk

PMID: 16338028
DOI: 10.1016/j.jhin.2005.04.011

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Bacteremia* / drug therapy
Bacteremia* / epidemiology
Bacteremia* / microbiology
Cross Infection* / drug therapy
Cross Infection* / epidemiology
Cross Infection* / microbiology
Drug Resistance, Bacterial
Enterococcus / drug effects*
Enterococcus / isolation & purification
Enterococcus / pathogenicity
Glycopeptides* / pharmacology
Glycopeptides* / therapeutic use
Humans
Laboratories, Hospital
Population Surveillance / methods*
Risk Factors
Surveys and Questionnaires
United Kingdom / epidemiology

Substances

Anti-Bacterial Agents
Glycopeptides